Announcements Trials
Browse Landscape

Phase

Phase 2 61Phase 3 13Phase 1/2 13Phase 1 11Phase 2/3 3Phase 4 2Phase NA 1

Status

Completed 4Unknown 3Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 2Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Cetuximab × Clear all
NCT02942706 2021-04-30

Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC

Ruijin Hospital

Phase 2/3 Unknown
200 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02978313 2016-11-30

Cetuximab Monotherapy Maintenance Treatment in mCRC

Ruijin Hospital

Phase 2/3 Unknown
500 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00509561 2012-12-18

Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

Wales Cancer Trials Unit

Phase 2/3 Unknown
259 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡